Trump Unveils Deals With 9 Pharma Companies to Reduce Drug Prices

WASHINGTON—President Donald Trump announced agreements with nine of the largest pharmaceutical companies to offer drugs to Americans at lower prices during a Roosevelt Room ceremony on Dec. 19. The deals with Amgen, Bristol Myers Squibb, Genentech, Merck, and five others will reduce costs for treatments related to autoimmune diseases, cancer, diabetes, and other disorders. Trump’s drive to obtain most-favored-nation pricing has now brought 14 of the 17 biggest drug manufacturers into the initiative after AstraZeneca, EMD Serono, Novo Nordisk, Lilly, and Pfizer signed deals earlier this year. “What was once considered impossible is now a reality,” a senior administration official told reporters during a briefing on Friday. “This is what bold leadership delivers.”...